Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Share-based Compensation (IS) (2011 - 2026)

Updated

Grace Therapeutics' Share-based Compensation (IS) was $105,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.2% from $302,000 a year earlier and down 42.3% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Share-based Compensation (IS) (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Grace Therapeutics' Share-based Compensation (IS) was $602,000 through Jun 30, 2026, down 24.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $798,000, up 9.3% from FY2025.

  • In earlier fiscal years, Share-based Compensation (IS) was $730,000 in FY2025 (-20.0%) and $913,000 in FY2024.
  • The fiscal Q1 2027 figure marks the lowest quarterly Share-based Compensation (IS) since fiscal Q1 2018.
  • Compared with a year earlier, Share-based Compensation (IS) was higher in three of the last five quarters, with an average decline of 5.6%.
  • Per Business Quant data, GRCE's Share-based Compensation (IS) in the three fiscal quarters before Q1 2027 was $182,000 (Q4 2026), $109,000 (Q3 2026) and $206,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 197,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105,000.00
Mar 31, 2026 182,000.00
Dec 31, 2025 109,000.00
Sep 30, 2025 206,000.00
Jun 30, 2025 302,000.00
Mar 31, 2025 130,000.00
Dec 31, 2024 160,000.00
Sep 30, 2024 202,000.00
Jun 30, 2024 238,000.00
Dec 31, 2018 254,560.25
Sep 30, 2018 249,380.44
Jun 30, 2018 194,564.91
Mar 31, 2018 212,042.70
Dec 31, 2017 259,756.94
Sep 30, 2017 235,234.87
Jun 30, 2017 26,773.80
Nov 30, 2016 155.00
Aug 31, 2016 210,000.00
May 31, 2016 64,000.00
Feb 29, 2016 108,000.00
API Access

Grace Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRCE&period=max&api_key=YOUR_API_KEY